RHOA and angioimmunoblastic T-cell lymphoma: As already described in nodal AITL, these data may suggest that RHOA mutation may be a secondary event in lymphomatous cells after other critical molecular events such as TET2 mutations that first occur in "premalignant" lymphocyte precursors13,17,40–42.